Lexicon Pharmaceuticals | 销售成本



金融业
股票价格
USD
资产
USD 225.58M
现金及等价物
USD 21.36M
销售成本
USD 17.81M
流动资产
USD 145.08M
流动负债
USD 34.84M
债务
USD 99.27M
股息收益率
0
EBIT
USD -49.63M
EBITDA
USD -49.48M
员工
285
EPS每股收益
USD -0.17
股本和储备
USD 129.44M
销售毛利
USD -16.16M
债务利息支出
USD 2.21M
贷款资金
USD 56.11M
市值
USD 306.6M
净收入
USD -53.43M
营业费用
USD 57M
营业利润
USD -55.35M
普通股股本
USD 245K
PE价格收益
12.44
税前利润
USD -53.43M
销售收入
USD 1.65M
销售和管理费用
USD 39.19M
股票
USD 168K
贸易债权人
USD 5.9M
应收帐款人
USD 2.62M


销售成本 更改 日
Abbott USD 4.92B 535M 2025-12
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
Agios Pharmaceuticals USD 1.68M 22K 2025-09
Akebia Therapeutics USD 8.13M 2.41M 2025-03
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
AstraZeneca USD 3.27B 471M 2025-12
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Coherus Biosciences USD 2.65M 31.2M 2025-03
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 73M 8.88M 2025-09
Illumina USD 400M 49M 2025-12
Insmed USD 30.9M 1.56M 2025-09
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 7.97B 689M 2025-12
Lexicon Pharmaceuticals USD 17.81M 3.41M 2024-06
MacroGenics USD 44.3M 5.4M 2025-09
MannKind USD 20.2M 365K 2025-09
Merck USD 3.32B 531M 2025-12
Moderna USD 207M 88M 2025-09
Novartis USD 3.54B 217M 2025-09
PTC Therapeutics USD 23.32M 7.83M 2025-09
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Thermo Fisher Scientific USD 7.58B 674M 2025-12
Ultragenyx Pharmaceutical USD 27.99M 4.99M 2025-09
United Therapeutics USD 100.9M 74.3M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Lexicon Pharmaceuticals 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.